🇰🇷 PIRLIMYCIN in South Korea

PIRLIMYCIN (PIRLIMYCIN) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

PIRLIMYCIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in South Korea

Frequently asked questions

Is PIRLIMYCIN approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for PIRLIMYCIN in South Korea?

Marketing authorisation holder not available in our data.